Solana Company
HealthcareNASDAQ:HSDT · NASDAQ Capital Market
+$0.03 today
Vol 0.38M · Avg 0.36M
Income Statement
Follow revenue through to earnings
Review sales, margins, expenses, and profit trends to see what is actually driving reported earnings over time.
Earnings Waterfall
Revenue to Net Income
Key Ratios
Analysis
$9.6M of revenue converted into -$136.8M of net income for the selected period. Gross margin is 38.4% and net margin is -17502.2%, showing how much revenue survives after costs and taxes. EPS is $-33.93, tying the income statement back to per-share earnings.
Income Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.0M +1057.1% | $520.0K -19.3% | $644.0K -18.2% | $787.0K +50.8% | $522.0K | $809.6M | $921.6M | $731.2M |
| Cost of Revenue | $500.0K -14.1% | $582.0K -0.2% | $583.0K +25.9% | $463.0K +55.4% | $298.0K | $725.6M | $804.0M | $882.4M |
| Gross Profit | $5.5M +8998.4% | -$62.0K -201.6% | $61.0K -81.2% | $324.0K +44.6% | $224.0K | $8.9B | $7.6B | $6.2B |
| Gross Margin | 91.7% +103.6pp | -11.9% -21.4pp | 9.5% -31.7pp | 41.2% -1.7pp | 42.9% | 9.8% | 28.9% | 38.3% |
| Research & Development | $3.5M -4.0% | $3.7M +24.4% | $2.9M -31.0% | $4.3M -28.8% | $6.0M | $983.2M | $1.3B | $490.4M |
| Selling, General & Admin | $23.1M +128.6% | $10.1M +9.1% | $9.3M -12.9% | $10.6M -12.6% | $12.2M | $620.6M | $923.0M | -$1.5B |
| Operating Expenses | $26.6M +92.5% | $13.8M +10.8% | $12.5M -21.2% | $15.8M -13.8% | $18.4M | $5.3B | $7.0B | $8.7B |
| Depreciation & Amortization | $0 -100.0% | $60.0K -63.0% | $162.0K -36.5% | $255.0K -18.3% | $312.0K | $374.2M | $1.2B | $631.8M |
| EBITDA | -$40.3M -191.6% | -$13.8M -14.0% | -$12.1M +16.5% | -$14.5M +18.6% | -$17.8M | -$15.2B | $6.8B | $9.3B |
| EBITDA Margin | -669.0% +1985.4pp | -2654.4% -774.5pp | -1880.0% -37.0pp | -1842.9% +1570.8pp | -3413.8% | 5.6% | 46.3% | 42.0% |
| Operating Income | -$21.1M -51.9% | -$13.9M -11.9% | -$12.4M +19.9% | -$15.5M +14.5% | -$18.1M | $12.3B | $14.0B | -$15.7B |
| Operating Margin | -351.0% +2322.6pp | -2673.7% -743.8pp | -1929.8% +41.7pp | -1971.5% +1503.9pp | -3475.5% | 16.6% | 24.1% | 22.0% |
| Interest Income | $0 | $0 -100.0% | $257.0K | $0 | $0 | -$1.5B | -$1.6B | $405.0M |
| Interest Expense | $635.0K +3635.3% | $17.0K | $0 -100.0% | $834.0K | $0 | $1.1B | $1.0B | $1.2B |
| Other Income / Expenses | -$19.8M -1014.8% | $2.2M -39.6% | $3.6M +147.8% | $1.4M +14340.0% | $10.0K | -$1.5B | $1.4B | $1.2B |
| Income Before Tax | -$40.9M -248.2% | -$11.7M -32.7% | -$8.8M +37.1% | -$14.1M +22.4% | -$18.1M | $3.3B | $4.9B | $3.6B |
| Pre-Tax Margin | -679.6% +1578.5pp | -2258.1% -883.9pp | -1374.2% +413.8pp | -1788.1% +1685.5pp | -3473.6% | 20.8% | 18.7% | 26.2% |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $1.3B | -$1.6B | $745.2M |
| Net Income | -$40.9M -248.2% | -$11.7M -32.7% | -$8.8M +37.1% | -$14.1M +22.4% | -$18.1M | $4.9B | $4.8B | $4.7B |
| Net Margin | -679.6% +1578.5pp | -2258.1% -883.9pp | -1374.2% +413.8pp | -1788.1% +1685.5pp | -3473.6% | 12.4% | 17.5% | 22.5% |
| EPS (Basic) | -$2 +57.3% | -$4 +40.5% | -$7 +72.1% | -$26 +85.9% | -$185 | $400.8M | $703.2M | $1.3B |
| EPS (Diluted) | -$2 +57.3% | -$4 +40.5% | -$7 +72.1% | -$26 +85.9% | -$185 | $766.2M | $609.4M | $452.6M |
| Weighted Avg Shares | $22.0M +713.6% | $2.7M +122.9% | $1.2M +125.2% | $539.9K +449.4% | $98.3K | $757.8M | $925.8M | $1.1B |
| Weighted Avg Shares (Diluted) | $22.0M +713.6% | $2.7M +122.9% | $1.2M +125.2% | $539.9K +449.4% | $98.3K | $1.2B | $924.4M | $678.0M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Electromed, Inc.
AMEX:ELMD
$307.52M
Perspective Therapeutics, Inc.
AMEX:CATX
$227.89M
Profound Medical Corp.
NASDAQ:PROF
$200.47M
InfuSystem Holdings, Inc.
AMEX:INFU
$184.46M
Inogen, Inc.
NASDAQ:INGN
$173.28M
Quanterix Corporation
NASDAQ:QTRX
$146.03M
TriSalus Life Sciences, Inc.
NASDAQ:TLSI
$142.92M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$128.21M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$122.48M
Outset Medical, Inc.
NASDAQ:OM
$83.23M
SEC Filings
Recent regulatory filings
No filings found.
How much revenue does HSDT generate?
Solana Company (HSDT) reported $6.02M of revenue in fiscal 2025.
Is HSDT profitable?
Solana Company (HSDT) reported -$40,890,000.00 of net income, with a net margin of -679.6%.
Explore More
Continue the stock analysis
Jump to another research area for this company.